As of April 19, 2025, Sagimet Biosciences (SGMT) has a market cap of $71.152 million USD. According to our data, Sagimet Biosciences is ranked No.7826 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $71.15 M |
-48.45%
|
Dec 31, 2024 | $0.14 B |
-16.97%
|
Dec 29, 2023 | $0.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Madrigal Pharmaceuticals
MDGL
|
$6.66 B |
-0.000 M
|
![]() USA
|
![]() Viking Therapeutics
VKTX
|
$2.69 B |
-0.000 M
|
![]() USA
|
![]() Akero Therapeutics
AKRO
|
$3.00 B |
-0.000 M
|
![]() USA
|
![]() Galmed Pharmaceuticals
GLMD
|
$3.12 M |
0.000 M
|
![]() Israel
|
![]() 89bio
ETNB
|
$0.88 B |
0.000 M
|
![]() USA
|
![]() Terns Pharmaceuticals
TERN
|
$0.21 B |
0.000 M
|
![]() USA
|
![]() Genfit
GNFT
|
$0.18 B |
1.329 M
|
![]() France
|
![]() Lipocine
LPCN
|
$16.05 M |
0.000 M
|
![]() USA
|
Market Cap | = | SGMT Stock Price | * | SGMT Shares Outstanding |
= | $2.21 | * | 30.67 M | |
= | $71.15 M |